Interleukin (IL)-1 alpha and IL-1 beta are encoded by two separate genes, b
ut both function as comitogens for lymphocyte activation. In this study, we
observed K-562 cells to express constitutively mRNA for IL-1 alpha, althou
gh IL-1 alpha was not detected in the growth-conditioned medium (GCM). Howe
ver, IL-1 beta mRNA was not expressed unless the cells had been treated wit
h phorbol myristate acetate (PMA), Both IL-1 alpha and IL-1 beta were detec
ted in the GCM after the cells had been cultured with PMA, suggesting that
IL-1 elaboration required PMA treatment. The K-562 cells treated with PMA d
ifferentiated to the myeloblastic stage, as observed by nuclear morphologic
properties by electron microscopy, PMA treatment induced de novo expressio
n of CD61 or gpIIIa, a marker associated with megakaryoblasts. These result
s showed that although K-562 cells constitutively expressed IL-1 alpha mRNA
, PMA treatment was required for secretion. On the other hand, both the exp
ression and secretion of LL-1 beta required treatment with PMA, This study
showed that K-562 cells treated with PMA differentiated to the myeloblastic
stage and expressed and secreted IL-1 alpha and IL-1 beta.